Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 47% ± 15% | |
lung | 12 studies | 28% ± 10% | |
intestine | 6 studies | 23% ± 8% | |
bone marrow | 4 studies | 41% ± 17% | |
adipose | 4 studies | 23% ± 10% | |
lymph node | 4 studies | 45% ± 15% | |
uterus | 3 studies | 24% ± 8% | |
breast | 3 studies | 19% ± 3% | |
liver | 3 studies | 33% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3847.97 | 578 / 578 | 100% | 38.48 | 1152 / 1155 |
breast | 100% | 2616.57 | 459 / 459 | 98% | 26.40 | 1095 / 1118 |
prostate | 98% | 1736.57 | 240 / 245 | 99% | 23.59 | 495 / 502 |
stomach | 95% | 1085.78 | 341 / 359 | 97% | 21.66 | 277 / 286 |
thymus | 98% | 1877.24 | 643 / 653 | 82% | 18.94 | 496 / 605 |
skin | 100% | 2468.04 | 1809 / 1809 | 76% | 16.38 | 358 / 472 |
intestine | 77% | 1985.14 | 745 / 966 | 97% | 20.70 | 513 / 527 |
bladder | 81% | 930.43 | 17 / 21 | 93% | 20.57 | 468 / 504 |
esophagus | 70% | 648.16 | 1017 / 1445 | 100% | 26.01 | 183 / 183 |
pancreas | 72% | 554.65 | 236 / 328 | 96% | 25.85 | 170 / 178 |
uterus | 64% | 677.09 | 109 / 170 | 96% | 19.33 | 442 / 459 |
kidney | 76% | 835.76 | 68 / 89 | 78% | 15.47 | 700 / 901 |
brain | 40% | 292.41 | 1053 / 2642 | 97% | 22.11 | 685 / 705 |
ovary | 37% | 290.27 | 66 / 180 | 96% | 20.08 | 411 / 430 |
adrenal gland | 90% | 910.25 | 231 / 258 | 41% | 4.55 | 95 / 230 |
adipose | 100% | 3287.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 82.75 | 29 / 29 |
peripheral blood | 100% | 11531.97 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 7611.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 34.28 | 45 / 45 |
blood vessel | 96% | 1788.36 | 1287 / 1335 | 0% | 0 | 0 / 0 |
heart | 54% | 485.74 | 461 / 861 | 0% | 0 | 0 / 0 |
liver | 11% | 81.09 | 25 / 226 | 33% | 4.08 | 134 / 406 |
muscle | 24% | 171.12 | 193 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.70 | 6 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000271 | Biological process | positive regulation of fibroblast apoptotic process |
GO_0006915 | Biological process | apoptotic process |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0090543 | Cellular component | Flemming body |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0005886 | Cellular component | plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0004672 | Molecular function | protein kinase activity |
Gene name | STK17B |
Protein name | STK17B protein Serine/threonine kinase 17b Serine/threonine-protein kinase 17B (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 2) Serine/threonine kinase 17b (Apoptosis-inducing) |
Synonyms | hCG_20077 DRAK2 |
Description | FUNCTION: Phosphorylates myosin light chains (By similarity). Acts as a positive regulator of apoptosis. . |
Accessions | U3KQF8 Q53QE7 Q6FG83 Q6FG98 ENST00000409228.5 ENST00000263955.9 ENST00000420683.1 C9JZJ1 O94768 ENST00000606789.1 |